AlphaFold predicted structure
PPT1 · P50897

Mean pLDDT
91.7/ 100
Very high
306 residues
Confidence breakdown
- Very high(≥ 90)82%
- Confident(70–90)6%
- Low(50–70)9%
- Very low(< 50)3%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
palmitoyl-protein thioesterase 1
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalEarly onset or syndromic epilepsy
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalLysosomal storage disorder
BIALLELIC, autosomal or pseudoautosomalNeuronal ceroid lipofuscinosis
BIALLELIC, autosomal or pseudoautosomalRetinal disorders
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomal+7 more panels — install the extension to see the full list inline on any page.
neuronal ceroid lipofuscinosis 1
neuronal ceroid lipofuscinosis
CLN1 disease
hereditary disease
Alzheimer disease
Parkinson disease
infantile neuronal ceroid lipofuscinosis
lysosomal storage disease
neurodegenerative disease
multiple sclerosis
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Palmitoyl-protein thioesterase 1
Has thioesterase activity against fatty acid thioesters with 14 -18 carbons, including palmitoyl-CoA, S-palmitoyl-N-acetylcysteamine, and palmitoylated proteins (PubMed:12855696, PubMed:26731412, PubMed:8816748). In contrast to PPT2, PPT1 can hydrolyze palmitoylated proteins and palmitoylcysteine (PubMed:12855696)
PPT1 · P50897

Mean pLDDT
91.7/ 100
Very high
306 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0